Introduction International guidelines recommend that adults with peripheral artery disease
(PAD) be prescribed antiplatelet, statin and antihypertensive medications. However, it is …

Introduction International guidelines recommend that adults with peripheral artery disease
(PAD) be prescribed antiplatelet, statin and antihypertensive medications. However, it is …

Introduction: Peripheral artery disease (PAD) guidelines recommend anti-platelet, lipid-
lowering, anti-hypertensive, diabetic, and smoking cessation therapies to prevent …

Objective Adherence to peripheral artery disease (PAD) treatment reduces the risk of
cardiovascular events and delays disease progression, but patients do not fully adhere to …

Secondary prevention of peripheral arterial disease (PAD) includes administration of
antiplatelet agents, and adherence to medication is a requirement for an effective treatment …

Background—Patients with peripheral artery disease (PAD) are at high risk of
cardiovascular events and benefit from aggressive secondary prevention; however, changes …

Background: Little is known about patterns of medication use and lifestyle counseling in
patients with peripheral artery disease (PAD) in the United States. Objectives: The authors …

Background Guideline‐based cardioprotective medical therapy is intended to reduce the
burden of adverse cardiovascular and limb outcomes in patients with peripheral artery …

Background Underuse of guideline‐recommended therapy in peripheral artery disease
(PAD) in administrative and procedural databases has been described, but reports on …

Background Underuse of cardiovascular medications for secondary prevention among
individuals with peripheral artery disease (PAD) has been reported. Little is known about …